Inspire Medical Systems, Inc. (INSP)

NYSE: INSP · Real-Time Price · USD

Compare

68.14

+1.81 (2.73%)

At close: Feb 10, 2026, 4:00 PM EST

68.14

0.00 (0.00%)

After-hours: Feb 10, 2026, 4:10 PM EST

Inspire Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	882.62	802.8	624.8	407.86	233.39	115.38
Revenue Growth (YoY)	16.81%	28.49%	53.19%	74.75%	102.28%	40.62%
Cost of Revenue	133.14	122.99	96.58	66.12	33.28	17.62
Gross Profit	749.48	679.82	528.22	341.74	200.12	97.76
Selling, General & Admin	604.19	529.61	451.96	320.69	202.62	127.87
Research & Development	108.56	114.13	116.54	68.65	37.35	26.09
Operating Expenses	712.75	643.74	568.49	389.33	239.97	153.97
Operating Income	36.73	36.08	-40.27	-47.59	-39.85	-56.21
Interest Expense	-0.04	-0.02	-	-1.68	-2.13	-2.12
Interest & Investment Income	19.09	23.25	20.56	5.05	0.13	1.09
Currency Exchange Gain (Loss)	0.2	-0.9	-0.2	-0.1	-	-
Other Non Operating Income (Expenses)	0.08	0.05	0.01	0.05	-0.12	0.15
Pretax Income	52.01	58.45	-19.91	-44.27	-41.97	-57.09
Income Tax Expense	7.46	4.94	1.25	0.61	0.07	0.12
Earnings From Continuing Operations	-	53.51	-21.15	-44.88	-42.04	-57.2
Net Income	44.56	53.51	-21.15	-44.88	-42.04	-57.2
Net Income to Common	44.56	53.51	-21.15	-44.88	-42.04	-57.2
Shares Outstanding (Basic)	30	30	29	28	27	26
Shares Outstanding (Diluted)	30	31	29	28	27	26
Shares Change (YoY)	-0.77%	4.24%	4.38%	2.97%	4.56%	9.53%
EPS (Basic)	1.51	1.80	-0.72	-1.60	-1.54	-2.19
EPS (Diluted)	1.48	1.75	-0.72	-1.60	-1.54	-2.19
Free Cash Flow	98.82	91.12	1.02	2.47	-24.79	-55.5
Free Cash Flow Per Share	3.29	2.98	0.04	0.09	-0.91	-2.13
Gross Margin	84.91%	84.68%	84.54%	83.79%	85.74%	84.73%
Operating Margin	4.16%	4.50%	-6.44%	-11.67%	-17.07%	-48.72%
Profit Margin	5.05%	6.67%	-3.39%	-11.00%	-18.01%	-49.58%
Free Cash Flow Margin	11.20%	11.35%	0.16%	0.61%	-10.62%	-48.10%
EBITDA	49.34	42.63	-37.43	-45.73	-38.63	-55.37
EBITDA Margin	5.59%	5.31%	-5.99%	-11.21%	-16.55%	-47.99%
D&A For EBITDA	12.61	6.55	2.85	1.86	1.22	0.84
EBIT	36.73	36.08	-40.27	-47.59	-39.85	-56.21
EBIT Margin	4.16%	4.50%	-6.44%	-11.67%	-17.07%	-48.72%
Effective Tax Rate	14.34%	8.46%	-	-	-	-
Advertising Expenses	-	94.9	100.3	74.3	47.8	26.4

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q